Whether the procedure adopted by the government for price fixation and review under the Drugs (Prices Control) Order was fair and in compliance with natural justice principles.
Whether the manufacturers were entitled to receive all pertinent information from the government to seek a proper review of the price fixation.
Whether delays in the disposal of review applications invalidated the price notifications.
Whether interim orders staying the implementation of price notifications served the public interest.